Substituted 3-oxo-1,2,5-thiadiazolidine 1,1-dioxides: a new class of potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G
Groutas, William C. ; Kuang, Rongze ; Venkataraman, Radhika
Groutas, William C.
Kuang, Rongze
Venkataraman, Radhika
An error occurred retrieving the object's statistics
Citations
Altmetric:
Authors
Groutas, William C.
Kuang, Rongze
Venkataraman, Radhika
Kuang, Rongze
Venkataraman, Radhika
Other Names
Wichita State University. Department of Chemistry
Location
Time Period
Advisors
Original Date
Digitization Date
Issue Date
1994-01-14
Type
Article
Genre
Keywords
Research Support, U.S. Gov't, P.H.S.
Subjects (LCSH)
Cathepsins/blood
Cyclic S-Oxides/pharmacology
Pancreatic Elastase/blood
Thiadiazoles/pharmacology
Cyclic S-Oxides/pharmacology
Pancreatic Elastase/blood
Thiadiazoles/pharmacology
Citation
Biochemical and biophysical research communications. 1994 Jan 14; 198(1): 341-9.
Abstract
A series of substituted 3-oxo-1,2,5-thiadiazolidine 1,1-dioxides has been synthesized and their in vitro inhibitory activity toward human leukocyte elastase and cathepsin G was investigated. These compounds were found to inactivate the two enzymes efficiently and in a time-dependent fashion.
Table of Contents
Description
Full text of this article is not available in SOAR.
Publisher
Elsevier
Journal
Book Title
Series
Biochemical and biophysical research communications
Biochem. Biophys. Res. Commun.
Biochem. Biophys. Res. Commun.
Digital Collection
Finding Aid URL
Use and Reproduction
Archival Collection
NLM
PubMed ID
DOI
ISSN
0006-291X
